BCR and Familial prostate cancer: Our study aimed to assess the density of selected immune cell subsets present in both intratumoral and peritumoral benign (non-tumor) regions of primary prostate cancer specimens, and to examine the association of immune cell subsets with biochemical recurrence (BCR) and the development of metastatic disease following radical prostatectomy.